Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Successful homotransplantation of the human kidney between identical twins.JAMA. 1956; 160: 277-282
- Liver transplantation. The last ten years.Surg Clin North Am. 1994; 74: 1133-1154
- Annual data report of the US Organ Procurement and Transplantation Network (OPTN) and the scientific registry of transplant recipients (SRTR). Introduction.Am J Transplant. 2013; 13: 8-10
- Heart and heart-lung transplantation, Papworth Hospital, 1979-1989.Clin Transpl. 1989; : 73-78
- Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis.J Chronic Dis. 1987; 40: 137S-158S
- Life satisfaction following heart transplantation.J Heart Transplant. 1985; 4: 446-449
- Quality of life after orthotopic heart transplantation.J Heart Lung Transplant. 1991; 10: 455-459
- The quality of life in renal transplantation--a prospective study.Transplantation. 1992; 54: 656-660
- Kidney transplantation improves quality of life.Transplant Proc. 1997; 29: 1569-1570
- The quality of life after liver transplantation.Transplant Proc. 1979; 11: 252-256
- The quality of survival after liver transplantation.Transplant Proc. 1988; 20: 594-597
- Health-related quality of life after liver transplantation: a meta-analysis.Liver Transpl Surg. 1999; 5: 318-331
- Long-term renal allograft survival in the United States: a critical reappraisal.Am J Transplant. 2011; 11: 450-462
- Developing new immunosuppression for the next generation of transplant recipients: the path forward.Am J Transplant. 2016; 16: 1094-1101
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin Pharmacol Ther. 2001; 69: 89-95
- The first successful organ transplants in man..JACS. 2005; 200: 5-9
- Significance of the positive crossmatch test in kidney transplantation.N Engl J Med. 1969; 280: 735-739
- Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.J Am Soc Nephrol. 2010; 21: 1398-1406
- Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study.Am J Transplant. 2007; 7: 864-871
- Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.Am J Transplant. 2012; 12: 1157-1167
- C1q assay for the detection of complement fixing antibody to HLA antigens.Methods Mol Biol. 2013; 1034: 305-311
- Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients.J Heart Lung Transplant. 2011; 30: 158-163
- C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation.Transplantation. 2011; 91: 342-347
- Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.Hum Immunol. 2011; 72: 849-858
- HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.Transplantation. 2003; 75: 884-889
- Novel aspects of epitope matching and practical application in kidney transplantation.Kidney Int. 2018; 93: 314-324
- HLA epitope matching in kidney transplantation: an overview for the general nephrologist.Am J Kidney Dis. 2018; 71: 720-731
- Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.Am J Transplant. 2013; 13: 3114-3122
- Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.Proc Natl Acad Sci U S A. 2009; 106: 4148-4153
- Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.Lancet. 2005; 365: 1570-1576
- Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants.Clin Transpl. 2003; : 449-452
- The association of antivascular endothelial cell antibody with hyperacute rejection: a case report.Surgery. 1986; 99: 637-640
- Novel antibodies associated with unexplained loss of renal allografts.Transpl Int. 1990; 3: 66-69
- Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody.Am J Transplant. 2012; 12: 1643-1649
- Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch.Transplantation. 1988; 46: 585-587
- Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.Nephrology (Carlton). 2015; 20: 75-78
- Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells.Transpl Immunol. 1997; 5: 321-327
- An association between antibodies specific for endothelial cells and renal transplant failure.Transpl Immunol. 1998; 6: 101-106
- Antibodies against MICA antigens and kidney-transplant rejection.N Engl J Med. 2007; 357: 1293-1300
- Angiotensin antibodies and focal segmental glomerulosclerosis.N Engl J Med. 2013; 368: 971-973
- Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.Clin Transplant. 2015; 29: 606-611
- A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.Sci Transl Med. 2014; 6: 256ra136
- Imperfect gold standards for kidney injury biomarker evaluation.J Am Soc Nephrol. 2012; 23: 13-21
- Rejection of the kidney allograft.N Engl J Med. 2010; 363: 1451-1462
- The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.Ann Transplant. 2011; 16: 90-98
- Clinical role of the renal transplant biopsy.Nat Rev Nephrol. 2012; 8: 110-121
- Complications of percutaneous renal biopsy: an analysis of 1,000 consecutive biopsies.Clin Nephrol. 1975; 4: 223-227
- Renal biopsy in high-risk patients with medical diseases of the kidney.Am J Kidney Dis. 2000; 36: 419-433
- Real-time ultrasound-guided renal biopsy with a biopsy gun in children: safety and efficacy.Acta Paediatr. 2001; 90: 1394-1397
- Safety and cost effectiveness of pediatric percutaneous renal biopsy.Pediatr Nephrol. 1996; 10: 493-495
- Safety and efficacy of kidney transplant biopsy: Tru-Cut needle vs sonographically guided biopsy gun.AJR Am J Roentgenol. 1993; 160: 325-326
- Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.N Engl J Med. 2003; 349: 125-138
- Urinary-cell mRNA and acute kidney-transplant rejection.N Engl J Med. 2013; 369: 1860-1861
- Chemokines, chemokine receptors, and allograft rejection.Immunity. 2001; 14: 377-386
- Expression of chemokines and chemokine receptors during human renal transplant rejection.Am J Kidney Dis. 2001; 37: 518-531
- Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction.Am J Transplant. 2004; 4: 432-437
- Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection.Am J Transplant. 2011; 11: 2228-2234
- Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.Am J Transplant. 2013; 13: 2634-2644
- Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis.Am J Transplant. 2009; 9: 1347-1353
- Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection.J Am Soc Nephrol. 2015; 26: 2840-2851
- Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.Kidney Int. 2014; 85: 258-264
- Molecular assessment of disease states in kidney transplant biopsy samples.Nat Rev Nephrol. 2016; 12: 534-548
- Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX Study.Am J Transplant. 2017; 17: 2851-2862
- Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study.Lancet. 2016; 388: 983-993
- Next-generation sequencing: from basic research to diagnostics.Clin Chem. 2009; 55: 641-658
- Donor-specific Cell-Free DNA as a biomarker in solid organ transplantation. A systematic review.Transplantation. 2018; https://doi.org/10.1097/TP.0000000000002482
- Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.J Heart Lung Transplant. 2017; 36: 1004-1012
- Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study.PLoS Med. 2017; 14: e1002286
- Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.Hum Immunol. 2017; 78: 342-349
- An Algorithm measuring donor cell-free DNA in plasma of cellular and solid organ transplant recipients that does not require donor or recipient genotyping.Front Cardiovasc Med. 2016; 3: 33
- Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation.Transplant Proc. 2015; 47: 2400-2403
- Integrated kidney exosome analysis for the detection of kidney transplant rejection.ACS Nano. 2017; 11: 11041-11046
- Infection in solid-organ transplant recipients.N Engl J Med. 2007; 357: 2601-2614
- Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients.J Am Soc Nephrol. 2015; 26: 3114-3122
- A meta-analysis of immunosuppression withdrawal trials in renal transplantation.J Am Soc Nephrol. 2000; 11: 1910-1917
- Therapeutic monitoring of calcineurin inhibitors for the nephrologist.Clin J Am Soc Nephrol. 2007; 2: 374-384
- Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.Am J Transplant. 2003; 3: 878-884
- Standardization and cross validation of alloreactive IFNgamma ELISPOT assays within the clinical trials in organ transplantation consortium.Am J Transplant. 2013; 13: 1871-1879
- Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.Transpl Immunol. 2006; 16: 232-237
- Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.Transplantation. 2004; 78: 1640-1646
- Interferon gamma ELISPOT testing as a risk-stratifying biomarker for kidney transplant injury: results from the CTOT-01 multicenter study.Am J Transplant. 2015; 15: 3166-3173
- Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP.Clin Diagn Lab Immunol. 2000; 7: 307-311
- Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay.Transplantation. 2006; 82: 663-668
- Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.Clin J Am Soc Nephrol. 2011; 6: 423-429
- Performance of the ImmuKnow assay in differentiating infection and acute rejection after kidney transplantation: a meta-analysis.Transplant Proc. 2014; 46: 3343-3351
- Serial ImmuKnow assay in stable kidney transplant recipients.Cent Eur J Immunol. 2014; 39: 96-99
- Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial.Transplantation. 2015; 99: 1625-1632
- Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.Clin Transplant. 2013; 27: E351-E358
- The role of B cells in solid organ transplantation.Semin Immunol. 2012; 24: 96-108
- Literature watch: implications for transplantation.Am J Transplant. 2013; 13: 1117
- HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers.Transplantation. 2007; 83: 982-988
- HLA-specific B cells: II. Application to transplantation.Transplantation. 2007; 83: 989-994
- Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA.Transplantation. 2013; 95: 701-704
- A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.J Immunol Methods. 1983; 65: 109-121
- A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals.Am J Transplant. 2012; 12: 1469-1478
- Quantification of HLA class II-specific memory B cells in HLA-sensitized individuals.Hum Immunol. 2015; 76: 129-136
- Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis.J Immunol. 2010; 185: 717-728
- Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response.Proc Natl Acad Sci U S A. 2005; 102: 14723-14728
- Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome.Am J Transplant. 2013; 13: 2855-2864
- Medical outcomes in African American live kidney donors: a matched cohort study.Am J Transplant. 2013; 13: 111-118
- Risk of end-stage renal disease following live kidney donation.JAMA. 2014; 311: 579-586
- Association of trypanolytic ApoL1 variants with kidney disease in African Americans.Science. 2010; 329: 841-845
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.Nat Genet. 2008; 40: 1175-1184
- APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.Kidney Int. 2016; 90: 389-395
- Late reoccurrence of collapsing FSGS after transplantation of a living-related kidney bearing APOL 1 risk variants without disease evident in donor supports the second hit hypothesis.Transplant Direct. 2017; 3: e185
- Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors.Ann Surg. 2018; 267: 1161-1168
- APOL1 genotype and renal function of black living donors.J Am Soc Nephrol. 2018; 29: 1309-1316
- Clinical genetic testing for APOL1: are we there yet?.Semin Nephrol. 2017; 37: 552-557
- Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response.J Am Soc Nephrol. 2018; 29: 2069-2080
- Transplantomics and biomarkers in organ transplantation: a report from the first international conference.Transplantation. 2011; 91: 379-382
Article info
Publication history
Published online: December 17, 2018
Footnotes
Disclosure Statement: Funding support was provided by NIH grants to the authors Dr.Choi T32DK007527 and Dr. Azzi R01AI134842 and the author Dr. Bano have no disclosure.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
